Although only a few drugs have yet been approved, numerous novel cytokines designed by different strategies have entered the clinical trials stage and achieved project milestones. Based on the well-established recombinant protein and antibody technology platform, series of cytokine-related research reagents, such as recombinant cytokines and their receptors, antibodies, ELISA kits, genes, etc., have been developed to support cytokine studies. Explore these new strategies for cytokine immunotherapy research.
Please check the highlighted fields and try again.
Please enter your first and last name.
Please enter the name of the company or institution you work at.
Please enter your mailing address.
Please enter the e-mail address you would like to be contacted at.